Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech NFE Q1 2026 Earnings Wider Loss Than Expected Yet Shares Rally 559 MSGE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher SPOT Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 6 FSEA Q3 2024 Earnings Modest Profitability Achieved Amidst Challenging Environment Rubico Inc RUBI Drops 74 as Key Support Level Approaches Antalpha Platform Holding ANTA Holds Steady at 802 as Market Awaits Catalyst Chemomab Therapeutics CMMB Stages a Sharp Rebound Can the Biotech Sustain Its Upward Momentum Greenland Mines Ltd GRML Faces Continued Pressure as Shares Test Key Support BWMX Q1 2026 Earnings EPS Misses Expectations Despite Slight Stock Uptick